Clinical Research Directory
Browse clinical research sites, groups, and studies.
A 3-month Study to Assess the Safety and Effectiveness of ONS-5010 in Subjects With Neovascular Age-related Macular Degeneration (AMD)
Sponsor: Outlook Therapeutics, Inc.
Summary
Multicenter, randomized, masked, controlled study of the safety and effectiveness of intravitreally administered ONS-5010.
Official title: Safety and Effectiveness of ONS-5010 Compared to Lucentis® in Subjects With Neovascular Age-related Macular Degeneration; NORSE EIGHT
Key Details
Gender
All
Age Range
50 Years - Any
Study Type
INTERVENTIONAL
Enrollment
400
Start Date
2024-01-24
Completion Date
2024-12-05
Last Updated
2026-06-30
Healthy Volunteers
No
Conditions
Interventions
bevacizumab
1.25 mg, intravitreal injection
ranibizumab
0.5mg, intravitreal injection
Locations (61)
Clinical Site
Arcadia, California, United States
Clinical Site
Bakersfield, California, United States
Clinical Site
Beverly Hills, California, United States
Clinical Site
Huntington Beach, California, United States
Clinical Site
Laguna Hills, California, United States
Clinical Site
Long Beach, California, United States
Clinical Site
Modesto, California, United States
Clinical Site
Oakland, California, United States
Clinical Site
Pasadena, California, United States
Clinical Site
Poway, California, United States
Clinical Site
Sacramento, California, United States
Clinical Site
Colorado Springs, Colorado, United States
Clinical Site
Lakewood, Colorado, United States
Clinical Site
Waterford, Connecticut, United States
Clinical Site
Coral Springs, Florida, United States
Clinical Site
Fort Lauderdale, Florida, United States
Clinical Site
Jacksonville, Florida, United States
Clinical Site
Orlando, Florida, United States
Clinical Site
Stuart, Florida, United States
Clinical Site
Oak Forest, Illinois, United States
Clinical Site
Oak Park, Illinois, United States
Clinical Site
Carmel, Indiana, United States
Clinical Site
Lenexa, Kansas, United States
Clinical Site
Lexington, Kentucky, United States
Clinical Site
Hagerstown, Maryland, United States
Clinical Site
Edina, Minnesota, United States
Clinical Site
Saint Louis Park, Minnesota, United States
Clinical Site
Jackson, Mississippi, United States
Clinical Site
Teaneck, New Jersey, United States
Clinical Site
Albuquerque, New Mexico, United States
Clinical Site
Liverpool, New York, United States
Clinical Site
Oceanside, New York, United States
Clinical Site
Rochester, New York, United States
Clinical Site
Westbury, New York, United States
Clinical Site
Asheville, North Carolina, United States
Clinical Site
Hickory, North Carolina, United States
Clinical Site
Wake Forest, North Carolina, United States
Clinical Site
Winston-Salem, North Carolina, United States
Clinical Site
Edmond, Oklahoma, United States
Clinical Site
Charleston, South Carolina, United States
Clinical Site
Florence, South Carolina, United States
Clinical Site
Ladson, South Carolina, United States
Clinical Site
West Columbia, South Carolina, United States
Clinical Site
Rapid City, South Dakota, United States
Clinical Site
Germantown, Tennessee, United States
Clinical Site
Abilene, Texas, United States
Clinical Site
Arlington, Texas, United States
Clinical Site
Austin, Texas, United States
Clinical Site
Beaumont, Texas, United States
Clinical Site
Bellaire, Texas, United States
Clinical Site
Dallas, Texas, United States
Clinical Site
Round Rock, Texas, United States
Clinical Site
San Antonio, Texas, United States
Clinical Site
San Antonio, Texas, United States
Clinical Site
The Woodlands, Texas, United States
Clinical Site
Willow Park, Texas, United States
Clinical Site
Salt Lake City, Utah, United States
Clinical Site
Fairfax, Virginia, United States
Clinical Site
Lynchburg, Virginia, United States
Clinical Site
Bellevue, Washington, United States
Clinical Site
Silverdale, Washington, United States